⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25067129 | 0.84 | BACE1 (0.32) | — | |
| SCHEMBL21962109 | 0.77 | FPR1 (0.32) | — | |
| SCHEMBL25066995 | 0.73 | PTGES (0.30) | — | |
| SCHEMBL21962228 | 0.72 | PIK3CD (0.30) | — | |
| SCHEMBL25067035 | 0.72 | PIK3CD (0.30) | — | |
| SCHEMBL25067270 | 0.68 | FFAR1 (0.46) | — | |
| SCHEMBL21962096 | 0.67 | FFAR1 (0.47) | — | |
| SCHEMBL22014946 | 0.67 | FFAR1 (0.40) | — | |
| SCHEMBL22014859 | 0.65 | CA2 (0.41) | — | |
| SCHEMBL21962332 | 0.65 | FFAR1 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230059136-A1 | THE COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY | NOVARTIS AG (CH) | 2023-02-23 | — | — | US | disclosed |
| WO-2020102574-A1 | THE COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY | NOVARTIS INFLAMMASOME RESEARCH, INC. (US) | 2020-05-22 | — | — | WO | disclosed |